Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Elucidating the Efficacy of the Bacille Calmette-Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione.

Abrahem R, Cao R, Robinson B, Munjal S, Cho T, To K, Ashley D, Hernandez J, Nguyen T, Teskey G, Venketaraman V.

J Clin Med. 2019 Sep 27;8(10). pii: E1556. doi: 10.3390/jcm8101556.

2.

Potentials of Host-Directed Therapies in Tuberculosis Management.

Dara Y, Volcani D, Shah K, Shin K, Venketaraman V.

J Clin Med. 2019 Aug 3;8(8). pii: E1166. doi: 10.3390/jcm8081166. Review.

3.

The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes.

Cao R, Islamoglu H, Teskey G, Gyurjian K, Abrahem R, Onajole OK, Lun S, Bishai W, Kozikowski AP, Fraix MP, Sathananthan A, Zhong L, Stec J, Venketaraman V.

Int Microbiol. 2019 Jun 19. doi: 10.1007/s10123-019-00086-0. [Epub ahead of print]

PMID:
31218537
4.

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity.

Cao R, Teskey G, Islamoglu H, Gutierrez M, Salaiz O, Munjal S, Fraix MP, Sathananthan A, Nieman DC, Venketaraman V.

Molecules. 2019 Feb 28;24(5). pii: E851. doi: 10.3390/molecules24050851.

5.
6.

Glutathione as a Marker for Human Disease.

Teskey G, Abrahem R, Cao R, Gyurjian K, Islamoglu H, Lucero M, Martinez A, Paredes E, Salaiz O, Robinson B, Venketaraman V.

Adv Clin Chem. 2018;87:141-159. doi: 10.1016/bs.acc.2018.07.004. Epub 2018 Aug 23. Review.

PMID:
30342710
7.

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis.

Teskey G, Cao R, Islamoglu H, Medina A, Prasad C, Prasad R, Sathananthan A, Fraix M, Subbian S, Zhong L, Venketaraman V.

Front Immunol. 2018 Sep 12;9:2069. doi: 10.3389/fimmu.2018.02069. eCollection 2018.

8.

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.

Cao R, Teskey G, Islamoglu H, Abrahem R, Munjal S, Gyurjian K, Zhong L, Venketaraman V.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01132-18. doi: 10.1128/AAC.01132-18. Print 2018 Nov.

9.

Tuberculous meningitis: a roadmap for advancing basic and translational research.

Jain SK, Tobin DM, Tucker EW, Venketaraman V, Ordonez AA, Jayashankar L, Siddiqi OK, Hammoud DA, Prasadarao NV, Sandor M, Hafner R, Fabry Z; NIH Tuberculous Meningitis Writing Group.

Nat Immunol. 2018 Jun;19(6):521-525. doi: 10.1038/s41590-018-0119-x. No abstract available.

10.

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection.

Islamoglu H, Cao R, Teskey G, Gyurjian K, Lucar S, Fraix MP, Sathananthan A, Chan JK, Venketaraman V.

J Clin Med. 2018 Mar 1;7(3). pii: E40. doi: 10.3390/jcm7030040.

11.

Restoring Cytokine Balance in HIV-Positive Individuals with Low CD4 T Cell Counts.

Valdivia A, Ly J, Gonzalez L, Hussain P, Saing T, Islamoglu H, Pearce D, Ochoa C, Venketaraman V.

AIDS Res Hum Retroviruses. 2017 Sep;33(9):905-918. doi: 10.1089/AID.2016.0303. Epub 2017 May 10.

12.

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection.

Warren E, Teskey G, Venketaraman V.

J Clin Med. 2017 Feb 7;6(2). pii: E15. doi: 10.3390/jcm6020015. Review.

13.

Data on pro-inflammatory cytokines IL-1β, IL-17, and IL-6 in the peripheral blood of HIV-infected individuals.

Saing T, Valdivia A, Hussain P, Ly J, Gonzalez L, Guilford FT, Pearce D, Venketaraman V.

Data Brief. 2016 Jul 19;8:1044-7. doi: 10.1016/j.dib.2016.07.023. eCollection 2016 Sep.

14.

Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process.

Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V.

BBA Clin. 2016 May 29;6:38-44. doi: 10.1016/j.bbacli.2016.05.006. eCollection 2016 Dec.

15.

Complement 3 Receptor Expression in Individuals with Type 2 Diabetes.

Ly J, Morris D, Lagman M, Ng C, Anderson S, Daliva J, Muwanas N, Tarash I, Ochoa C, Sathananthan A, Venketaraman V.

Recent Pat Antiinfect Drug Discov. 2016;11(2):174-182. doi: 10.2174/1574891X11666160608121617.

PMID:
27291248
16.

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis - A Close View of the Immune System.

Venketaraman V.

Front Immunol. 2015 Oct 22;6:545. doi: 10.3389/fimmu.2015.00545. eCollection 2015. No abstract available.

17.

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione.

Allen M, Bailey C, Cahatol I, Dodge L, Yim J, Kassissa C, Luong J, Kasko S, Pandya S, Venketaraman V.

Front Immunol. 2015 Oct 5;6:508. doi: 10.3389/fimmu.2015.00508. eCollection 2015. Review.

18.

Mycobacterium tuberculosis.

Venketaraman V, Kaushal D, Saviola B.

J Immunol Res. 2015;2015:857598. doi: 10.1155/2015/857598. Epub 2015 Aug 4. No abstract available.

19.

Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals.

Ly J, Lagman M, Saing T, Singh MK, Tudela EV, Morris D, Anderson J, Daliva J, Ochoa C, Patel N, Pearce D, Venketaraman V.

J Interferon Cytokine Res. 2015 Nov;35(11):875-87. doi: 10.1089/jir.2014.0210. Epub 2015 Jul 2.

20.

Investigating the causes for decreased levels of glutathione in individuals with type II diabetes.

Lagman M, Ly J, Saing T, Kaur Singh M, Vera Tudela E, Morris D, Chi PT, Ochoa C, Sathananthan A, Venketaraman V.

PLoS One. 2015 Mar 19;10(3):e0118436. doi: 10.1371/journal.pone.0118436. eCollection 2015.

21.

Glutathione synthesis is compromised in erythrocytes from individuals with HIV.

Morris D, Ly J, Chi PT, Daliva J, Nguyen T, Soofer C, Chen YC, Lagman M, Venketaraman V.

Front Pharmacol. 2014 Apr 11;5:73. doi: 10.3389/fphar.2014.00073. eCollection 2014.

22.

An elucidation of neutrophil functions against Mycobacterium tuberculosis infection.

Morris D, Nguyen T, Kim J, Kassissa C, Khurasany M, Luong J, Kasko S, Pandya S, Chu M, Chi PT, Ly J, Lagman M, Venketaraman V.

Clin Dev Immunol. 2013;2013:959650. doi: 10.1155/2013/959650. Epub 2013 Nov 7.

23.

Characterization of dendritic cell and regulatory T cell functions against Mycobacterium tuberculosis infection.

Morris D, Gonzalez B, Khurasany M, Kassissa C, Luong J, Kasko S, Pandya S, Chu M, Chi PT, Bui S, Guerra C, Chan J, Venketaraman V.

Biomed Res Int. 2013;2013:402827. doi: 10.1155/2013/402827. Epub 2013 May 23.

24.

Glutathione supplementation improves macrophage functions in HIV.

Morris D, Guerra C, Khurasany M, Guilford F, Saviola B, Huang Y, Venketaraman V.

J Interferon Cytokine Res. 2013 May;33(5):270-9. doi: 10.1089/jir.2012.0103. Epub 2013 Feb 14.

PMID:
23409922
25.

Glutathione and infection.

Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, Mehta R, Gray D, Saviola B, Venketaraman V.

Biochim Biophys Acta. 2013 May;1830(5):3329-49. doi: 10.1016/j.bbagen.2012.10.012. Epub 2012 Oct 23. Review.

PMID:
23089304
26.

Control of Mycobacterium tuberculosis growth by activated natural killer cells.

Guerra C, Johal K, Morris D, Moreno S, Alvarado O, Gray D, Tanzil M, Pearce D, Venketaraman V.

Clin Exp Immunol. 2012 Apr;168(1):142-52. doi: 10.1111/j.1365-2249.2011.04552.x.

27.

Unveiling the mechanisms for decreased glutathione in individuals with HIV infection.

Morris D, Guerra C, Donohue C, Oh H, Khurasany M, Venketaraman V.

Clin Dev Immunol. 2012;2012:734125. doi: 10.1155/2012/734125. Epub 2011 Dec 29.

28.

Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals.

Guerra C, Morris D, Sipin A, Kung S, Franklin M, Gray D, Tanzil M, Guilford F, Khasawneh FT, Venketaraman V.

PLoS One. 2011;6(12):e28378. doi: 10.1371/journal.pone.0028378. Epub 2011 Dec 2.

29.

Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA).

Pumerantz A, Muppidi K, Agnihotri S, Guerra C, Venketaraman V, Wang J, Betageri G.

Int J Antimicrob Agents. 2011 Feb;37(2):140-4. doi: 10.1016/j.ijantimicag.2010.10.011. Epub 2010 Dec 3.

PMID:
21130608
30.

Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection.

Guilford T, Morris D, Gray D, Venketaraman V.

HIV AIDS (Auckl). 2010;2:211-8. doi: 10.2147/HIV.S11977. Epub 2010 Oct 29.

31.

Control of mycobacterium tuberculosis infection by glutathione.

Connell ND, Venketaraman V.

Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):214-26. Review.

PMID:
19832692
32.

Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing.

Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB.

Microb Pathog. 2008 Sep;45(3):173-80. doi: 10.1016/j.micpath.2008.05.007. Epub 2008 Jun 5.

33.

Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis.

Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V.

J Interferon Cytokine Res. 2008 Mar;28(3):153-65. doi: 10.1089/jir.2007.0095.

PMID:
18338948
34.

Glutathione levels and immune responses in tuberculosis patients.

Venketaraman V, Millman A, Salman M, Swaminathan S, Goetz M, Lardizabal A, David Hom, Connell ND.

Microb Pathog. 2008 Mar;44(3):255-61. Epub 2007 Sep 26.

PMID:
17959342
35.

Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection.

Talaue MT, Venketaraman V, Hazbón MH, Peteroy-Kelly M, Seth A, Colangeli R, Alland D, Connell ND.

J Bacteriol. 2006 Jul;188(13):4830-40.

36.

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects.

Venketaraman V, Rodgers T, Linares R, Reilly N, Swaminathan S, Hom D, Millman AC, Wallis R, Connell ND.

AIDS Res Ther. 2006 Feb 20;3:5.

37.
38.

Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis.

Venketaraman V, Dayaram YK, Talaue MT, Connell ND.

Infect Immun. 2005 Mar;73(3):1886-9.

39.

Nitric oxide regulation of L-arginine uptake in murine and human macrophages.

Venketaraman V, Talaue MT, Dayaram YK, Peteroy-Kelly MA, Bu W, Connell ND.

Tuberculosis (Edinb). 2003;83(5):311-8.

PMID:
12972344
40.

Role of glutathione in macrophage control of mycobacteria.

Venketaraman V, Dayaram YK, Amin AG, Ngo R, Green RM, Talaue MT, Mann J, Connell ND.

Infect Immun. 2003 Apr;71(4):1864-71.

41.

Modulation of J774.1 macrophage L-arginine metabolism by intracellular Mycobacterium bovis BCG.

Peteroy-Kelly MA, Venketaraman V, Talaue M, Seth A, Connell ND.

Infect Immun. 2003 Feb;71(2):1011-5.

43.

Cytolytic P2X purinoceptors.

Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR.

Cell Death Differ. 1998 Mar;5(3):191-9. Review.

Supplemental Content

Loading ...
Support Center